Diagnosis and Treatment of Intracardiac Thrombus
暂无分享,去创建一个
C. Trankle | A. Robinson | Z. Gertz | J. Kron | Xin Wei | Kylie Weigel | M. Patel
[1] Jeroen J. Bax,et al. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. , 2020, Journal of the American College of Cardiology.
[2] C. Kramer,et al. Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. , 2020, JAMA cardiology.
[3] E. Vicaut,et al. Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus. , 2020, Journal of the American College of Cardiology.
[4] J. Weisel,et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli , 2020, Scientific Reports.
[5] J. Kalman,et al. The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant? , 2020, JACC. Clinical electrophysiology.
[6] S. Bangalore,et al. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis. , 2020, Journal of the American College of Cardiology.
[7] W. Hua,et al. Outcome of non‐vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation , 2020, Journal of cardiovascular electrophysiology.
[8] J. Tijssen,et al. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. , 2019, The New England journal of medicine.
[9] M. Packer. HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial Fibrillation. , 2019, JACC. Heart failure.
[10] M. Akçakaya,et al. Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study. , 2019, Circulation. Cardiovascular imaging.
[11] M. Mack,et al. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. , 2019, Journal of the American College of Cardiology.
[12] A. Magalski,et al. Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus. , 2019, The American journal of cardiology.
[13] P. Kułakowski,et al. RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study , 2019, Archives of medical science : AMS.
[14] Deepak L. Bhatt,et al. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. , 2019, Journal of the American College of Cardiology.
[15] Hugh Calkins,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Heart rhythm.
[16] Correction to: Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States. , 2018, Circulation.
[17] V. Reddy,et al. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes , 2018, Circulation.
[18] J. Cleland,et al. Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease , 2018, The New England journal of medicine.
[19] I. Roifman,et al. Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echocardiography for diagnosing left atrial appendage thrombi , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[20] P. Kirchhof,et al. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial , 2018, European heart journal.
[21] T. Huynh,et al. Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. , 2017, The Canadian journal of cardiology.
[22] S. Smyth,et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series , 2017, Journal of Thrombosis and Thrombolysis.
[23] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[24] Wen Cheng,et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study , 2017, The Lancet.
[25] S. Vallurupalli,et al. Challenges in management of left ventricular thrombus , 2017, Therapeutic advances in cardiovascular disease.
[26] J. Daubert,et al. Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. , 2017, The American journal of cardiology.
[27] J. Leipsic,et al. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation , 2017, Clinical Research in Cardiology.
[28] J. Freedman,et al. Thrombosis and platelets: an update. , 2016, European Heart Journal.
[29] Roxana Mehran,et al. Prosthetic Heart Valve Thrombosis. , 2016, Journal of the American College of Cardiology.
[30] C. Terkelsen,et al. Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications. , 2016, Journal of the American College of Cardiology.
[31] R. McNamara,et al. Left ventricular thrombi after STEMI in the primary PCI era: A systematic review and meta-analysis. , 2016, International journal of cardiology.
[32] G. Lip,et al. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). , 2016, American heart journal.
[33] D. Packer,et al. Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes , 2016, Journal of Interventional Cardiac Electrophysiology.
[34] J. Leipsic,et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. , 2016, European heart journal.
[35] Christopher A. Aakre,et al. Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] A. Garg,et al. The Risk of Major Hemorrhage with CKD. , 2016, Journal of the American Society of Nephrology : JASN.
[37] Deepak L. Bhatt,et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2015, The New England journal of medicine.
[38] A. Webster,et al. Risk of Stroke in Patients with ESRD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[39] G. Wright,et al. Echocardiography vs. Cardiac Magnetic Resonance Imaging for the Diagnosis of Left Ventricular Thrombus: A Systematic Review. , 2015, The Canadian journal of cardiology.
[40] G. Lip,et al. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. , 2015, Circulation. Heart failure.
[41] Y. Song,et al. Anticoagulation in ischemic left ventricular aneurysm. , 2015, Mayo Clinic proceedings.
[42] A. Capucci,et al. Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events , 2014, Circulation.
[43] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[44] P. Azadani,et al. Risk Factors and Prognosis for Clot Formation on Cardiac Device Leads , 2013, Pacing and clinical electrophysiology : PACE.
[45] Christopher A. Aakre,et al. Stroke or Transient Ischemic Attack in Patients With Transvenous Pacemaker or Defibrillator and Echocardiographically Detected Patent Foramen Ovale , 2013, Circulation.
[46] D. Atar,et al. Mass screening for silent atrial fibrillation in high risk patients - preliminary results from the STROKESTOP trial , 2013 .
[47] D. Holmes,et al. An update on transcatheter aortic valve replacement. , 2013, Current problems in cardiology.
[48] M. T. Ryan,et al. Supplemental Digital Content , 2013 .
[49] Sean M. O'Brien,et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. , 2012, Journal of the American College of Cardiology.
[50] Shunichi Homma,et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. , 2012, The New England journal of medicine.
[51] S. Achenbach,et al. Left ventricular thrombus attenuation characterization in cardiac computed tomography angiography. , 2012, Journal of cardiovascular computed tomography.
[52] F. Marchlinski,et al. Mobile Thrombus on Device Leads in Patients Undergoing Ablation: Identification, Incidence, Location, and Association With Increased Pulmonary Artery Systolic Pressure , 2011, Circulation.
[53] D. S. Houston,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[54] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[55] B. Slaná,et al. Autopsy and clinical context in deceased patients with implanted pacemakers and defibrillators: intracardiac findings near their leads and electrodes. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[56] Bijoy K Khandheria,et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Card , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[57] J. Saver,et al. Cryptogenic stroke and patent foramen ovale , 2008, Current opinion in cardiology.
[58] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[59] J. Koistinen,et al. Transesophageal Echocardiography in the Diagnosis of Thrombosis Associated with Permanent Transvenous Pacemaker Electrodes , 2006, Pacing and clinical electrophysiology : PACE.
[60] Richard D. White,et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. , 2006, American heart journal.
[61] J. Tabet,et al. Treatment of left ventricular thrombi with a low molecular weight heparin. , 2005, International journal of cardiology.
[62] L. Frost,et al. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. , 2001, Archives of internal medicine.
[63] J. Thomas,et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. , 2000, American heart journal.
[64] J. Anderson,et al. The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads. , 1995, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[65] P. Vaitkus,et al. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. , 1993, Journal of the American College of Cardiology.
[66] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[67] S. Vollset,et al. Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. , 1988, British heart journal.
[68] C. Visser,et al. Two dimensional echocardiography in the diagnosis of left ventricular thrombus. A prospective study of 67 patients with anatomic validation. , 1983, Chest.
[69] A. Belanger,et al. The Framingham study. , 1976, British medical journal.
[70] J. Wyatt,et al. Study , 2022, Evaluation Methods in Biomedical and Health Informatics.
[71] R. Siegel,et al. Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation. , 2019, The American journal of cardiology.
[72] A. Magalski,et al. Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation. , 2019, The American journal of cardiology.
[73] R. Khouzam,et al. Stress-induced thrombus: prevalence of thromboembolic events and the role of anticoagulation in Takotsubo cardiomyopathy. , 2018, Annals of translational medicine.
[74] A. Ducci,et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2016, The New England journal of medicine.
[75] M. Jinzaki,et al. Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR. , 2016, JACC. Cardiovascular imaging.
[76] G. Cho,et al. Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents. , 2013, Journal of atherosclerosis and thrombosis.
[77] H. Kok,et al. Left ventricular non-compaction cardiomyopathy. , 2012, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.
[79] A. Niessner. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[80] R. Troughton,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[81] G. F. Manzillo,et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. , 1999, Chest.
[82] N. P. Rabinovich,et al. [Intracardiac thrombus]. , 1952, Klinicheskaia meditsina.